Display options
Cite
Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro". Drug Metab Dispos. 2021;49(3):287-288doi: 10.1124/dmd.117.075358err.
(2021). Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro". Drug metabolism and disposition: the biological fate of chemicals, 49(3), 287-288. https://doi.org/10.1124/dmd.117.075358err
"Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro"." Drug metabolism and disposition: the biological fate of chemicals vol. 49,3 (2021): 287-288. doi: https://doi.org/10.1124/dmd.117.075358err
Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro". Drug Metab Dispos. 2021 Mar;49(3):287-288. doi: 10.1124/dmd.117.075358err. PMID: 33593806.
Copy Download .nbib Format: NLM
Share it on

Drug Metab Dispos. 2021 Mar;49(3):287-288. doi: 10.1124/dmd.117.075358err.

Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro".

Drug metabolism and disposition: the biological fate of chemicals

[No authors listed]

PMID: 33593806 DOI: 10.1124/dmd.117.075358err

[No abstract available.]

Publication Types